Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-26 @ 12:24 AM
NCT ID:
NCT05940194
Pre Assignment Details:
This is the phase 2 (part 2) of the phase 1/2 trial of COVIVAC vaccine. After providing informed consent, participants were screened and then randomized to receive either of 2 COVIVAC dose or AZD1222 in the 1:1:1 ratio. Each participant received 2 injections with 28 days apart.
Recruitment Details:
The screening and enrollment were conducted from 11 Aug 2021 to 23 August 2021 at the District Health Center of Vu Thu district, Thai Binh province. Total 737 subjects were screened, and 374 subjects were randomized to 3 treatment arms (124 subjects in COVIVAC 3µg arm, 125 subjects in COVIVAC 6µg arm and 125 in the AZD122 arm).
Study:
NCT05940194
Study Brief:
Results Section:
NCT05940194